Absolutely spot on - guys dont even worry about the latest pump and dump...the company is a turnaround story in the making. when it gets regulatory approval, we will be looking at a $40-80 mil market cap...especially if market picks up. Its way too cheap at these prices. Load up as much as you can, IMO. DYOR. If it gets regulatory approval, it should be priced as a phase two biotech stock with minimal R&D requirements + the dental business which I'm confident the company will turnaround in the process to become FCF +.
- Forums
- ASX - By Stock
- IHL
- Ann: Medicinal Cannabis Product Licensing Applications
Ann: Medicinal Cannabis Product Licensing Applications, page-35
-
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online